1. Barnett, J.H., K. Xu, J. Heron, et al. Cognitive effects of genetic variation in monoamine neurotransmitter systems: A population‐based study of COMT, MAOA, and 5HTTLPR. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. (2011) 156(2): 158–67.
2. Dauvilliers, Y., M. Tafti, H.P. Landolt. Catechol-O-methyltransferase, dopamine, and sleep-wake regulation. Sleep medicine reviews. (2015) 22: 47–53.
3. de la Mora, M.P., A. Gallegos-Cari, Y. Arizmendi-García, et al. Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: structural and functional analysis. Progress in neurobiology. (2010) 90(2): 198–216.
4. Pezze, M.A., J. Feldon. Mesolimbic dopaminergic pathways in fear conditioning. Progress in neurobiology. (2004) 74(5): 301–-20.
5. Meyer-Lindenberg, A., D.R. Weinberger. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews Neuroscience. (2006) 7(10): 818–27.
6. NIH/National Institute of Mental Health. Gene Enhances Prefrontal Function At A Price. ScienceDaily. www.sciencedaily.com/releases/2003/05/030508074640.htm. Accessed January 22, 2017.
7. Jensen, C.J., F. Demol, R. Bauwens, et al. Astrocytic β2 Adrenergic Receptor Gene Deletion Affects Memory in Aged Mice. PLoS One. (2016) 11(10): e0164721.
8. Minowa, M.T., S.H. Lee, M.M. Mouradian. Autoregulation of the human D1A dopamine receptor gene by cAMP. DNA and cell biology. (1996) 15(9): 759–67.